Clinical Trial Update: Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

A completed pediatric safety and efficacy trial update for Gabapen under a regulatory post-marketing commitment plan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsies Partial

Drugs mentioned

• Gabapen

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Epilepsies, Partial | Status: COMPLETED | Results posted: 2016-10-06